Bisphenol A Modulates Autophagy and Exacerbates Chronic Kidney Damage in Mice.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Jul 2021
Historique:
received: 31 05 2021
revised: 28 06 2021
accepted: 29 06 2021
entrez: 20 7 2021
pubmed: 21 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Bisphenol A (BPA) is a ubiquitous environmental toxin that accumulates in chronic kidney disease (CKD). Our aim was to explore the effect of chronic exposition of BPA in healthy and injured kidney investigating potential mechanisms involved. In C57Bl/6 mice, administration of BPA (120 mg/kg/day, i.p for 5 days/week) was done for 2 and 5 weeks. To study BPA effect on CKD, a model of subtotal nephrectomy (SNX) combined with BPA administration for 5 weeks was employed. In vitro studies were done in human proximal tubular epithelial cells (HK-2 line). Chronic BPA administration to healthy mice induces inflammatory infiltration in the kidney, tubular injury and renal fibrosis (assessed by increased collagen deposition). Moreover, in SNX mice BPA exposure exacerbates renal lesions, including overexpression of the tubular damage biomarker Hepatitis A virus cellular receptor 1 ( BPA deregulates autophagy flux and redox protective mechanisms, suggesting a potential mechanism of BPA deleterious effects in the kidney.

Sections du résumé

BACKGROUND BACKGROUND
Bisphenol A (BPA) is a ubiquitous environmental toxin that accumulates in chronic kidney disease (CKD). Our aim was to explore the effect of chronic exposition of BPA in healthy and injured kidney investigating potential mechanisms involved.
METHODS METHODS
In C57Bl/6 mice, administration of BPA (120 mg/kg/day, i.p for 5 days/week) was done for 2 and 5 weeks. To study BPA effect on CKD, a model of subtotal nephrectomy (SNX) combined with BPA administration for 5 weeks was employed. In vitro studies were done in human proximal tubular epithelial cells (HK-2 line).
RESULTS RESULTS
Chronic BPA administration to healthy mice induces inflammatory infiltration in the kidney, tubular injury and renal fibrosis (assessed by increased collagen deposition). Moreover, in SNX mice BPA exposure exacerbates renal lesions, including overexpression of the tubular damage biomarker Hepatitis A virus cellular receptor 1 (
CONCLUSIONS CONCLUSIONS
BPA deregulates autophagy flux and redox protective mechanisms, suggesting a potential mechanism of BPA deleterious effects in the kidney.

Identifiants

pubmed: 34281243
pii: ijms22137189
doi: 10.3390/ijms22137189
pmc: PMC8268806
pii:
doi:

Substances chimiques

Antioxidants 0
Benzhydryl Compounds 0
Phenols 0
bisphenol A MLT3645I99

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Am Soc Nephrol. 1999 Aug;10(8):1815-23
pubmed: 10446951
Autophagy. 2017 Jun 3;13(6):997-1003
pubmed: 28441075
J Recept Signal Transduct Res. 2020 Dec;40(6):570-583
pubmed: 32515636
Autophagy. 2015;11(7):1130-45
pubmed: 26039325
Cytotechnology. 2015 Jan;67(1):145-55
pubmed: 24337652
Oxid Med Cell Longev. 2018 Feb 18;2018:3082438
pubmed: 29670679
Iran J Basic Med Sci. 2019 Mar;22(3):315-523
pubmed: 31156794
Environ Mol Mutagen. 2017 Mar;58(2):60-71
pubmed: 28181297
Kidney Int. 2013 Apr;83(4):741-8
pubmed: 23302717
J Am Soc Nephrol. 2010 Jun;21(6):1041-1051
pubmed: 20378825
Int J Nephrol. 2013;2013:437857
pubmed: 23997953
Antioxid Redox Signal. 2016 Oct 20;25(12):657-684
pubmed: 26906673
Cell. 2011 Sep 2;146(5):682-95
pubmed: 21884931
Annu Rev Physiol. 2020 Feb 10;82:297-322
pubmed: 31640469
Int J Mol Sci. 2015 Oct 22;16(10):25154-67
pubmed: 26506346
Chemosphere. 2018 Sep;206:1-8
pubmed: 29723747
Environ Sci Pollut Res Int. 2020 Jun;27(16):20104-20116
pubmed: 32239407
Kidney Int. 2016 Nov;90(5):950-964
pubmed: 27325184
J Biol Chem. 2006 May 19;281(20):14474-85
pubmed: 16522639
Toxicol Mech Methods. 2016 May;26(4):295-300
pubmed: 27117342
Biochem Biophys Res Commun. 2018 Oct 12;504(4):641-646
pubmed: 30205956
PLoS One. 2018 Mar 12;13(3):e0193288
pubmed: 29529055
Acta Pol Pharm. 2011 Nov-Dec;68(6):867-73
pubmed: 22125951
Kidney Int. 2017 Jan;91(1):4-6
pubmed: 28003091
J Steroid Biochem Mol Biol. 2011 Oct;127(1-2):27-34
pubmed: 21605673
Crit Rev Toxicol. 2011 Apr;41(4):263-91
pubmed: 21438738
Int J Exp Pathol. 2016 Oct;97(5):369-379
pubmed: 27925325
Nephrology (Carlton). 2012 Feb;17(2):148-59
pubmed: 22085202
Toxicol Mech Methods. 2013 May;23(4):273-80
pubmed: 23193990
Histol Histopathol. 2018 Aug;33(8):803-814
pubmed: 29446059
Int J Nephrol. 2012;2012:465897
pubmed: 22577546
Kidney Int. 2007 Oct;72(8):985-93
pubmed: 17687258
J Am Soc Nephrol. 2016 May;27(5):1566-74
pubmed: 26432902
Regul Toxicol Pharmacol. 2016 Aug;79:106-107
pubmed: 26851507
PLoS Med. 2020 Oct 14;17(10):e1003384
pubmed: 33052911
Kidney Int. 2012 Jun;81(11):1131-9
pubmed: 22398408
Nat Rev Endocrinol. 2017 May;13(5):250
pubmed: 28281566
Food Addit Contam. 2005 Jan;22(1):65-72
pubmed: 15895613
Kidney Int. 2017 Jan;91(1):70-85
pubmed: 27678159
Front Endocrinol (Lausanne). 2019 Feb 06;10:30
pubmed: 30787907
Cardiorenal Med. 2013 Dec;3(4):254-64
pubmed: 24474954
Toxicol Appl Pharmacol. 2008 Apr 1;228(1):114-34
pubmed: 18207480
Kidney Int. 2005 Apr;67(4):1216-33
pubmed: 15780075
Zool Res. 2018 Mar 18;39(2):72-86
pubmed: 29515089
Reprod Toxicol. 2015 Dec;58:119-30
pubmed: 26307436
IUBMB Life. 2019 Jul;71(7):1041-1047
pubmed: 31091348
Toxicol Lett. 2015 Sep 2;237(2):165-6
pubmed: 25758025
Toxins (Basel). 2020 Jun 01;12(6):
pubmed: 32492843
Semin Nephrol. 2014 Jan;34(1):27-33
pubmed: 24485027
Environ Health Perspect. 2004 Mar;112(4):465-79
pubmed: 15033597
Int J Environ Res Public Health. 2019 Aug 28;16(17):
pubmed: 31466361
FASEB J. 2014 Nov;28(11):4719-28
pubmed: 25103225
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):398-405
pubmed: 29339356
Pediatrics. 2011 Nov;128(5):873-82
pubmed: 22025598
FEBS Lett. 2010 Apr 2;584(7):1374-8
pubmed: 20153326
Mol Cell Biol. 2009 May;29(9):2359-71
pubmed: 19255143
Cells. 2019 Jan 16;8(1):
pubmed: 30654583
Cell. 2010 Feb 5;140(3):313-26
pubmed: 20144757
Med Hypotheses. 2020 Mar 11;140:109675
pubmed: 32200183
Front Pharmacol. 2019 Oct 08;10:1192
pubmed: 31649546
J Dev Orig Health Dis. 2018 Apr;9(2):208-214
pubmed: 29103408
Naunyn Schmiedebergs Arch Pharmacol. 2010 Jul;382(1):51-61
pubmed: 20499049
Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i89-i97
pubmed: 28391346
Interdiscip Toxicol. 2018 Oct;11(3):209-216
pubmed: 31736635
Front Endocrinol (Lausanne). 2019 Sep 04;10:598
pubmed: 31551929
Environ Res. 2009 Aug;109(6):797-801
pubmed: 19464675
Toxicol Appl Pharmacol. 2010 Oct 1;248(1):1-11
pubmed: 20655935
Exp Ther Med. 2020 Jan;19(1):33-44
pubmed: 31853270
J Pathol. 2010 May;221(1):3-12
pubmed: 20225336
Nephrol Dial Transplant. 2011 Mar;26(3):759-61
pubmed: 21343587
Nat Rev Cancer. 2017 Sep;17(9):528-542
pubmed: 28751651
Antioxidants (Basel). 2020 Mar 16;9(3):
pubmed: 32187996
Toxicol Ind Health. 2016 Aug;32(8):1381-1390
pubmed: 25548375
J Am Soc Nephrol. 2011 May;22(5):902-13
pubmed: 21493778
J Toxicol Sci. 2002 Dec;27(5):433-9
pubmed: 12533913
J Am Soc Nephrol. 2012 Jul;23(7):1258-70
pubmed: 22626821
J Cell Biol. 2005 Nov 21;171(4):603-14
pubmed: 16286508
J Am Soc Nephrol. 2014 Dec;25(12):2835-46
pubmed: 24854279
Pathol Res Pract. 1990 Aug;186(4):491-506
pubmed: 1701048
Nat Rev Endocrinol. 2014 Jun;10(6):322-37
pubmed: 24663220
J Cell Sci. 2011 Aug 15;124(Pt 16):2692-701
pubmed: 21771882
Environ Pollut. 2021 Jan 1;268(Pt A):115896
pubmed: 33187850
Am J Kidney Dis. 1995 Dec;26(6):982-94
pubmed: 7503075
BMC Nephrol. 2017 Feb 15;18(1):63
pubmed: 28201996
Ecotoxicol Environ Saf. 2019 Dec 15;185:109684
pubmed: 31541948
Environ Toxicol. 2018 Mar;33(3):325-332
pubmed: 29214717
J Am Soc Nephrol. 2015 May;26(5):1040-52
pubmed: 25406339
Environ Health Perspect. 2005 Apr;113(4):391-5
pubmed: 15811827
Antioxidants (Basel). 2020 May 10;9(5):
pubmed: 32397641
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2141-2149
pubmed: 27852662
Sci Total Environ. 2019 Sep 1;681:175-182
pubmed: 31103655
Mol Cell Endocrinol. 2012 May 6;354(1-2):74-84
pubmed: 22249005
Clin Exp Nephrol. 2010 Apr;14(2):112-22
pubmed: 20013139
Environ Toxicol. 2017 Aug;32(8):1977-1989
pubmed: 27539358
Mutat Res Genet Toxicol Environ Mutagen. 2014 Jul 15;769:29-33
pubmed: 25344109
Nat Rev Nephrol. 2014 Sep;10(9):493-503
pubmed: 24981817
Int J Hyg Environ Health. 2015 Mar;218(2):212-9
pubmed: 25435060
Essays Biochem. 2017 Dec 12;61(6):609-624
pubmed: 29233872
Chemosphere. 2019 Nov;234:682-689
pubmed: 31234085
Am J Pathol. 2010 Apr;176(4):1767-78
pubmed: 20150430
Environ Res. 2007 Jan;103(1):9-20
pubmed: 16750524
J Am Soc Nephrol. 2020 Sep;31(9):2026-2042
pubmed: 32631974
Toxicol Ind Health. 2014 Aug;30(7):581-97
pubmed: 23024108
Kidney Int. 2010 Dec;78(11):1136-53
pubmed: 20736988
Toxicology. 2006 Sep 21;226(2-3):79-89
pubmed: 16860916
J Prev Med Public Health. 2010 Mar;43(2):131-7
pubmed: 20383046
Am J Transl Res. 2020 Feb 15;12(2):649-659
pubmed: 32194912
J Am Soc Nephrol. 2008 May;19(5):863-70
pubmed: 18287557
Environ Health Perspect. 2015 Jul;123(7):643-50
pubmed: 25775505
J Toxicol Sci. 2003 Aug;28(3):165-71
pubmed: 12974608

Auteurs

Alberto Ruiz Priego (AR)

Division of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz-UAM/IRSIN, 28040 Madrid, Spain.

Emilio González Parra (EG)

Division of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz-UAM/IRSIN, 28040 Madrid, Spain.

Sebastián Mas (S)

Division of Nephrology and Hypertension, IIS-Fundación Jiménez Díaz-UAM/IRSIN, 28040 Madrid, Spain.

José Luis Morgado-Pascual (JL)

Cellular Biology, Physiology and Immunology Department, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, 14004 Cordoba, Spain.

Marta Ruiz-Ortega (M)

Molecular and Cellular Biology in Renal and Vascular Pathology, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid Faculty of Medicine, 28040 Madrid, Spain.

Sandra Rayego-Mateos (S)

Molecular and Cellular Biology in Renal and Vascular Pathology, IIS-Fundación Jiménez Díaz, Universidad Autónoma Madrid Faculty of Medicine, 28040 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH